Celldex Therapeutics, Inc.

Q1 2023 13F Holders

Symbol
CLDX
CUSIP
15117B202
Type
Equity
Class
COM NEW
Num filers
165
Total reported value, excl. options
$1.78B
Manager Report Date Value ($000) Shares Option Type